QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.024711v1 70/2/736    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lanzafame, A. A. Articles by Christopoulos, A. Search for Related Content PubMed PubMed Citation Articles by Lanzafame, A. A. Articles by Christopoulos, A.

Interaction Studies of Multiple Binding Sites on M₄ Muscarinic Acetylcholine Receptors

Drug Discovery Biology Laboratory, Department of Pharmacology, Monash University, Victoria, Australia (A.C., P.M.S.); and Department of Pharmacology, University of Melbourne, Victoria, Australia (A.A.L.)

This study investigated the reciprocal cross-interactions between two distinct allosteric sites on the M₄ muscarinic acetylcholine receptor (mAChR) in the absence or presence of different orthosteric ligands. Initial studies revealed that two novel benzimidazole allosteric modulators, 17--hydroxy-17--ethy nyl-delta(4)-androstano[3,2-b]pyrimido[1,2-a]benzimidazole (WIN 62,577) and 17--hydroxy-17--ethynyl-5--androstano[3,2-b]pyrimido[1,2-a]benzimidazole (WIN 51,708), exhibited different degrees of positive, negative, or close-to-neutral cooperativity with the orthosteric site on M₁ or M₄ mAChRs, depending on the chemical nature of the orthosteric radioligand that was used [[³H]N-methylscopolamine ([³H]NMS) versus [³H]quinuclidinylbenzilate ([³H]QNB)]. The largest window for observing an effect (negative cooperativity) was noted for the combination of WIN 62,577 and [³H]QNB at the M₄ mAChR. Experiments involving the combination of these two ligands with unlabeled agonists [acetylcholine, 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium (McN-A-343), or xanomeline] revealed low degrees of negative cooperativity between WIN 62,577 and each agonist, whereas stronger negative cooperativity was observed against atropine. It is interesting that when these experiments were repeated using the prototypical modulators heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl)-ammonium bromide (C₇/3-phth), alcuronium, or brucine (which act at a separate allosteric site), WIN 62,577 exhibited negative cooperativity with each modulator when the orthosteric site was unoccupied, but this switched to neutral cooperativity when the receptor was occupied by [³H]QNB. Dissociation kinetic experiments using [³H]NMS and combination of C₇/3-phth with WIN 62,577 also provided evidence for neutral cooperativity between the two allosteric sites when the orthosteric site is occupied. Together, these results provide insight into the nature of the interaction between two distinct allosteric sites on the M₄ mAChR and how this interaction is perturbed upon occupancy of the orthosteric site.

Address correspondence to: Dr. Arthur Christopoulos, Drug Discovery Biology Laboratory, Department of Pharmacology, Building 13E, Monash University, Clayton, 3800, Victoria, Australia. E-mail: arthur.christopoulos{at}med.monash.edu.au

This article has been cited by other articles:

				K. J. Mansfield, J. J. Chandran, K. J. Vaux, R. J. Millard, A. Christopoulos, F. J. Mitchelson, and E. Burcher Comparison of Receptor Binding Characteristics of Commonly Used Muscarinic Antagonists in Human Bladder Detrusor and Mucosa J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 893 - 899. [Abstract] [Full Text] [PDF]

				L. H. Heitman, K. Ye, J. Oosterom, and A. P. IJzerman Amiloride Derivatives and a Nonpeptidic Antagonist Bind at Two Distinct Allosteric Sites in the Human Gonadotropin-Releasing Hormone Receptor Mol. Pharmacol., June 1, 2008; 73(6): 1808 - 1815. [Abstract] [Full Text] [PDF]

				J. A. Goodwin, E. C. Hulme, C. J. Langmead, and B. G. Tehan Roof and Floor of the Muscarinic Binding Pocket: Variations in the Binding Modes of Orthosteric Ligands Mol. Pharmacol., December 1, 2007; 72(6): 1484 - 1496. [Abstract] [Full Text] [PDF]

				L. T. May, V. A. Avlani, C. J. Langmead, H. J. Herdon, M. D. Wood, P. M. Sexton, and A. Christopoulos Structure-Function Studies of Allosteric Agonism at M2 Muscarinic Acetylcholine Receptors Mol. Pharmacol., August 1, 2007; 72(2): 463 - 476. [Abstract] [Full Text] [PDF]